Orazephin®
INDICATION: Antibacterial
Orazephin® CR is an oral version of a widely used intravenous antibiotic Ceftriaxone.
![](https://orxpharmaceuticals.com/wp-content/uploads/2021/11/orx-orazephin-photo.png)
Discover Orazephin®
![drug-overview drug-overview](https://orxpharmaceuticals.com/wp-content/uploads/2021/11/drug-overview-100x100.png)
Overview
Ceftriaxone is currently one of the most important and effective broad spectrum antibiotics used to treat over ten different infectious diseases including meningitis and post-surgical prophylaxis.
![drug-phase drug-phase](https://orxpharmaceuticals.com/wp-content/uploads/2021/11/drug-phase-100x100.png)
Phase
Orazephin® CR is currently in Phase I clinical trial.
![drug-US-market drug-US-market](https://orxpharmaceuticals.com/wp-content/uploads/2021/11/drug-US-market-100x100.png)
US Market ($B USD)
The estimated market for Orazephin® in the United States is $0.75 Billion USD.
![drug-global-market drug-global-market](https://orxpharmaceuticals.com/wp-content/uploads/2021/11/drug-global-market-100x100.png)
Global Market ($B USD)
The estimated market for Orazephin® globally is $1.3 Billion USD.